Plasma Cell Leukaemia (PCL): A Review
Published: 2021-09-14
Page: 298-300
Issue: 2021 - Volume 4 [Issue 4]
Emmanuel Ifeanyi Obeagu
*
Department of Medical Laboratory Science, Imo State University, Owerri, Nigeria.
Ebube Chioma Udemezue
Department of Medical Laboratory Science, Evanqel University, Akaeze Ebonyi State, Nigeria.
Blessing Oluchi Akalonu
Department of Medical Laboratory Science, Maddona University Nigeria, Elele Campus, Rivers State, Nigeria.
Quratulain Babar
Department of Biochemistry, Government College University, Faisalabad, Pakistan.
*Author to whom correspondence should be addressed.
Abstract
Leukemia is a blood and bone marrow malignancy. Chronic lymphocytic leukemia (CLL), acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML), and acute myeloid leukemia are the four main kinds of leukemia (AML). The pathological diagnosis of plasma cell leukemia is based on histological, immunophenotypic, and cytogenetic findings in addition to the circulating plasma cell count.
Keywords: Chronic lymphocytic leukaemia, acute lymphocytic leukaemia, chronic myelogenous leukaemia, acute myeloid leukaemia